Natural Products and Medicinal Plants Research

May 23-24, 2022 | Austria

Natural Products
Conferenceseries LLC Ltd is an amalgamation of Open Access Publications and worldwide international science conferences and events. 

Spotlight

Follow-on drugs, also referred to as ‘next-generation drugs’, are ‘an established practice’ among drug innovators. They are one of the most effective R&D strategies implemented by drug innovators, and can be considered a cannibalization or switching strategy. In a nutshell, it is a timely switch from a mature/firstgeneration drug to its next-generation, improved version. Given the fixed patent term and limited market exclusivity of drugs, cannibalization has been instrumental in maintaining the market share for drug makers.


OTHER PAST CONFERENCES

The Future of Pharmacy

November 11, 2022 | UK

Join us and discover how much pharmacy is changing. It's a day for you to listen, to learn and to discuss - as well as to enjoy meeting all your fellow professionals.

Pharma Manufacturing And Automation

November 15, 2022 | USA

Join over 300 senior representatives across two days of cutting-edge presentations on the biggest issues and opportunities in drug product manufacturing and digital transformation.

World Congress on Pharmaceutical Chemistry

November 10-11, 2022 | Germany

The main aim of Pharmaceutical Chemistry conference 2022 provides interaction between Pharmacists, Drug delivery experts, Pharma industries, R&D department, Young Researchers, Ph.D. scholars,

80TH FIP WORLD CONGRESS OF PHARMACY AND PHARMACEUTICAL SCIENCES

September 18-22, 2022 | Spain

At this critical time, when the challenges presented by the COVID-19 pandemic are still current and on the minds of healthcare professionals, we must take the opportunity to create more comprehensive plans to better manage health crises that may be on the horizon.

Spotlight

Follow-on drugs, also referred to as ‘next-generation drugs’, are ‘an established practice’ among drug innovators. They are one of the most effective R&D strategies implemented by drug innovators, and can be considered a cannibalization or switching strategy. In a nutshell, it is a timely switch from a mature/firstgeneration drug to its next-generation, improved version. Given the fixed patent term and limited market exclusivity of drugs, cannibalization has been instrumental in maintaining the market share for drug makers.

resources